Gutiérrez LA, Laourou PEL, Álvarez DJÁ, Rodríguez CBB, Gutiérrez ÁAA

Language: Spanish
References: 23
Page: 5-16
PDF size: 243.49 Kb.

ABSTRACT

Introduction: The diabetes mellitus type 2 is a chronic and systemic illness. It has been observed that it has a narrow relationship with the obesity, what has given place to the emergence of the term "diabesidad." It is a growing problem the increase of the cardiovascular risk in people that suffer diabesity so its prevention is necessary.
Objective: To determine the cardiovascular global risk and it relationship with the obesity in the diabetic patients of the north area of Güines.
Methodological design: An observational descriptive and traverse study was carried out it stops in diabetic patients that attended the consultation of diabetes mellitus of north area of Güines. The study universe was divided in overweight and non-overweight, the cardiovascular risk was calculated.
Results: The 77% of the investigated patients was valued as overweight, it prevalencing the cardiovascular moderate risk and the possibility of developing cardiovascular events. It was less probable in those patients than in those presenting alone overweight detected by index of corporal mass. The most frequently opposing lesions were the estenosis of the retinianas arteries (45,3%) and the presence of the atherosclerotic badge (37,5%).
Conclusions: The diabesidad is a frequent phenomenon in the diabetic type 2 that participated in the present investigation. The probability of developing cardiovascular events in the overweight diagnosed patients by Index of corporal mass is low, this is increased if the used method is the calculation of the circumference of the waist and, it is even higher in those patients where the calculation of the overweight coincides for both indexes.

REFERENCES

1. Inclán Acosta A, Pérez Rodríguez A, Ramos Conte R, Hernández Rosales D, Medina García C. Influencia de la escuela para diabéticos en el control metabólico de estos pacientes. MEDISAN. 2001; 5(2):24.

2. Programa Nacional de Diabetes. En: http://www.sld.cu/galerias/pdf/sitios/diabetes/programanacionaldediabetes.pdf. Consultado el viernes, 26 de febrero de 2010, 15:00h.

3. La diabetes afectará a 366 millones de personas en 2030. INFOMED Especialidades. En: http://www.sld.cu/verpost.php?blog=http://articulos.sld.cu/diabetes&post_id=854&c=2 8&tipo=2&idblog=32&p=1&n=dbl. Consultado el viernes, 26 de febrero de 2010, 15:00h.

4. Díaz Díaz O, Valenciaga Rodríguez JL, Domínguez Alonso E. Comportamiento epidemiológico de la diabetes mellitus en el municipio de Güines. Rev. Cubana Hig Epidemiol. 2004; 42(1).

5. Mather KJ, Steinberg HD, Baron AD. Weight loss and endothelial function in obesity. Diabetes Care. 2003; 26:1927-28.

6. Cho E, Rimm EB, Stampfer MJ, Willet WC, Hu FB. The impact of diabetes mellitus and prior myocardial infarction on mortality from all causes and from coronary heart disease in men. J Am Coll Cardiol. 2002; 40:954-60.

7. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn, R, et al. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classifications of diabetes mellitus. Diabetes Care. 2003;26 (Suppl 1):5-20.

8. Grupo de prevención cardiovascular del programa de actividades preventivas y promoción de la salud (PAPPS) de la Sociedad Española de Medicina de Familia y Comunitaria (semFYC). Guía de prevención cardiovascular. Madrid: Sersa, 1996; p. 12- 6.

9. Grupo de prevención cardiovascular del programa de actividades preventivas y promoción de la salud (PAPPS) de la Sociedad Española de Medicina de Familia y Comunitaria (semFYC). Guía de prevención cardiovascular en atención primaria. Barcelona: semFYC ed., 2003; p. 15-20.

10. James P, Rigby N. Estrategias radicales para prevenir la obesidad y la diabetes. Diabetes Voice. 2004; 49:8-10.

11. Solís Villanueva J. Industria Alimentaria y Diabesidad. Lima: ALAD; 2007.

12. Di Corleto PE, Gimbrone MA. Vascular endothelium. En: Fuster V, Ross R, Topol EJ, (ed). Atherosclerosis and Coronary Artery Disease. Philadelphia: Lippincott-Raven Publishers; 1996.

13. Masana L, Redón J (edits). Visión integrada del paciente con riesgo cardiovascular. Madrid: ERGON; 2003.

14. Alfonzo Guerra JP. Obesidad. Epidemia del siglo XXI. La Habana: Editorial Científico- Técnica; 2008.

15. Sierra ID, Mendivil CO, et al. Hacia el manejo práctico de la Diabetes Mellitus Tipo 2. 2 ed. Bogotá: NOVO NORDISK; 2005.

16. González-Juanatey JR, Grigorian-Shamagian L, Juiz-Crespo MA, Sánchez-Loureiro M, Rodríguez-Moldes E, Dopico-Pita J, et al. Impacto pronóstico de la localización de la enfermedad aterosclerosa previa en pacientes diabéticos. Estudio Barbanza-diabetes. Rev Esp Cardiol. 2008; 61:1168-77. En: http://www.doyma.es/cardio/ctl_servlet?_f=40&ident=13127848

17. Arpa Gámez A, González Sotolongo O, Roldós Cuza E, Borges Helps A, Acosta Vaillant R. El síndrome metabólico como factor de riesgo para la disfunción endotelial. Rev Cubana Med Milit. 2007; 36(1).

18. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005; 115: 911-9.

19. Rodríguez Porto AL, Sánchez León M, Martínez Valdez L. Síndrome Metabólico. Rev Cubana Endocrinol. 2002; 13(3):238.

20. Reyes CAD. Adiponectina: El tejido adiposo más allá de la reserva inerte de energía. Revista de Endocrinología y Nutrición 2007; 15(3):149-155. En: http://www.sld.cu/galerias/pdf/sitios/diabetes/adiponectinael_ tejido_adiposo_mas_alla_de_la_reserva_inerte_de_energia.pdf

21. Gelfand EV, Cannon CP. Rimonabant: A cannabinoid receptor type 1 blocker for management of multiple cardiometabolic risk factors. Journal of the ACC 2006; 47(10): 1919-1926.

22. Vasudevan AR, Ballantyne CM. Cardiometabolic risk assessment: an approach to the prevention of cardiovascular disease and diabetes mellitus. Clin Cornerstone. 2005; 7(2- 3):7-16.

23. Simón A, Castro A, Kaski JC. Avances en el conocimiento de la disfunción endotelial y su aplicación en la práctica clínica. Rev Cubana Med. 2001; 40(3):212-22.